
ASPI Stock Forecast & Price Target
ASPI Analyst Ratings
Bulls say
ASP Isotopes Inc. has demonstrated substantial revenue growth, reporting approximately $16.7 million in Q4, reflecting an annual increase of about 1299.6% and a sequential rise of 241.7%, driven primarily by heightened product revenue and significant contributions from construction services. The management’s positive sentiment regarding anticipated volume growth and early SPECT dose deliveries positions the company for a transformative phase, especially with indications of a potential revenue surge beginning mid-2026. Furthermore, the broader market outlook for helium, expected to double in demand by 2035 with a projected value of approximately USD 132 million in 2025, underscores the strategic importance of ASP Isotopes’ advancements in isotope production technology.
Bears say
ASP Isotopes Inc. reported a gross margin that significantly missed estimates, declining to approximately 8.7% in 3Q25 from 27.0% in the prior year, highlighting inefficiencies and operational challenges. The company also faced a widening net loss of $75.7 million in 4Q25, compared to $9.2 million in 4Q24, indicating deteriorating financial performance amid ongoing revenue delays related to isotope production. Furthermore, the adverse impact of broader economic factors, including decreased liquidity and credit availability, increased inflation, and rising interest rates, raises concerns about the company's ability to meet its strategic goals and maintain operational stability.
This aggregate rating is based on analysts' research of ASP Isotopes Inc and is not a guaranteed prediction by Public.com or investment advice.
ASPI Analyst Forecast & Price Prediction
Start investing in ASPI
Order type
Buy in
Order amount
Est. shares
0 shares